PLACPublic Lands Advisory Committee (various locations)
PLACPacifiCare Life Assurance Company (Salt Lake City, UT)
PLACPublic Library Access Card
PLACProduct Liability Advisory Council, Inc.
PLACPrior Learning Assessment Center (academic credit assessment)
PLACPattern Languages: Addressing Challenges
References in periodicals archive ?
Diagnostic company diaDexus (Other OTC:DDXS) stated on Thursday that the traditional 510(k) submission of the PLAC Test for Lp-PLA2 Activity was found to contain all of the necessary information needed to proceed with the substantive review by the US Food and Drug Administration.
She acted as her husband's adviser for cracking down on crime and corruption, and was responsible for sending two people -- including the PLAC secretary in Wushan County -- to prison.
chief medical officer of diaDexus, said that the PLAC test fills an important, unmet clinical need.
All the studies used the PLAC test to measure levels of Lp-PLA2.
PLAC test results are expected to help predict CHD risk in patients-with normal LDL cholesterol levels and no traditional heart disease risk factors, such as smoking, type 2 diabetes, or obesity.
We are confident that our renewed collaboration with Corgenix will provide us with the necessary manufacturing and support capabilities as we continue to see increased global acceptance of our PLAC Test," said Brian Ward, diaDexus' President and Chief Executive Officer.
Cardiovascular company diaDexus Inc (OTC Markets:DDXS) reported on Tuesday that it has started a clinical programme to support the submission of its PLAC Test for Lp-PLA2 Activity.
In a study of more than 1,300 patients, people with LDL, or bad, cholesterol below 130 were at higher risk of coronary heart disease if they scored high on the PLAC test.
M2 PHARMA-July 17, 2014-FDA accepts diaDexus' 510(k) filing for PLAC Test for Lp-PLA2 Activity
The PLAC test, a simple blood test that measures Lp-PLA2, may help determine if an individual is at an increased risk for heart disease.
M2 PHARMA-May 1, 2014-US diaDexus wraps up validation study of PLAC Test for Lp-PLA2 Activity
M2 PHARMA-October 16, 2013-diaDexus Inc reports launch of clinical programme to support the submission of its PLAC Test for Lp-PLA2 Activity(C)2013 M2 COMMUNICATIONS